Abstract
In 2007, the US gastrointestinal (GI) device market consisted of videoscopes,
endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps,
enteral feeding devices, hemostasis devices, CE device, esophageal dilation
balloons, GI stents, virtual colonoscopy systems, polypectomy snares,
retrieval devices, and reprocessed Biopsy forceps.
Driving market growth over the forecast period will be product innovation,
such as Alveolus' ALIMAXX-E esophageal stent. New device technologies often
garner higher average selling prices (ASPs), thus fueling revenue growth.
View Cart
